Percutaneous ventricular assist devices have been used for high-risk ventricular tachycardia ablation when hemodynamic decompensation is expected. Utilizing a case example, we present our experience with development of a coordinated, team-based approach focused on peri-procedural management of patients with high-risk ventricular tachycardia.

JACC Editor-in-Chief 

Julia Grapsa, MD, PhD, FACC

CME Editor 

Nadeen N. Faza, MD, FACC

Authors
Aditya Bharadwaj, MD
Melissa D. McCabe, MD MSCR
Tahmeed Contractor, MD
Rahul Bhardwaj, MD

Important Dates

Date of Release: June 1, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: May 31, 2023